Dietary Vitamin B12

Overview

Vitamin B12 (cobalamin) is a water-soluble vitamin with a complex cobalt-containing structure. It is unique among vitamins in that it is synthesized exclusively by microorganisms, making animal products and fortified foods the primary dietary sources. The body maintains substantial hepatic stores (2-5 mg), allowing deficiency to develop slowly over years. HealthKit tracks dietary vitamin B12 intake in micrograms.

Biological Functions

Vitamin B12 serves as a cofactor for two essential human enzymes:

• Methionine synthase: Converts homocysteine to methionine, regenerating tetrahydrofolate (THF) in the process. This reaction links B12 to folate metabolism and DNA synthesis.
• Methylmalonyl-CoA mutase: Converts methylmalonyl-CoA to succinyl-CoA in odd-chain fatty acid and certain amino acid metabolism. This mitochondrial enzyme is critical for energy production and myelin synthesis.

Downstream effects:

• DNA synthesis: Via folate regeneration, B12 is essential for purine and pyrimidine synthesis
• Red blood cell formation: Adequate B12 prevents megaloblastic anemia
• Neurological function: Maintains myelin sheath integrity; deficiency causes neurological damage
• Homocysteine regulation: Helps maintain cardiovascular health
• Energy metabolism: Supports mitochondrial function

Health Significance

Vitamin B12 deficiency is common, especially in elderly populations and those following plant-based diets, with significant neurological and hematological consequences. Unlike many water-soluble vitamins, B12 deficiency can cause irreversible neurological damage if untreated. The body's storage capacity means clinical deficiency may take years to manifest after inadequate intake begins.

Clinical Interpretation Guidelines

When reviewing patient vitamin B12 intake data:

• Intake vs. absorption: Adequate dietary intake does not guarantee adequate status; absorption requires intrinsic factor and gastric acid
• Consider absorption capacity: Patients over 50, those with GI conditions, or on certain medications may not absorb food-bound B12 efficiently
• Supplement form matters: Crystalline B12 in supplements/fortified foods is more bioavailable than food-bound B12
• Evaluate dietary pattern: Strict vegans without supplementation will become deficient
• Correlate with symptoms: Neurological symptoms may precede anemia
• Order serum testing: Dietary intake data should be correlated with serum B12, methylmalonic acid (MMA), and homocysteine levels

Deficiency

Hematological manifestations:

• Megaloblastic (macrocytic) anemia: Large, immature red blood cells with elevated MCV
• Pancytopenia in severe cases
• Hypersegmented neutrophils on peripheral smear
• Elevated LDH and indirect bilirubin (ineffective erythropoiesis)

Neurological manifestations (may occur without anemia):

• Subacute combined degeneration of the spinal cord
• Peripheral neuropathy: Numbness, tingling, "pins and needles" (often starting in feet)
• Ataxia and balance problems
• Cognitive impairment, memory loss, dementia-like symptoms
• Depression, irritability, personality changes
• Optic neuropathy (rare)

Other manifestations:

• Glossitis (smooth, beefy-red tongue)
• Angular cheilitis
• Elevated homocysteine (cardiovascular risk)

At-risk populations:

• Vegans and strict vegetarians: No reliable plant sources of B12
• Elderly (>60 years): 10-30% have food-bound B12 malabsorption due to atrophic gastritis
• Patients with pernicious anemia: Autoimmune destruction of intrinsic factor-producing parietal cells
• Post-bariatric surgery patients: Reduced intrinsic factor production and absorptive surface
• Patients with GI disorders: Crohn's disease, celiac disease, bacterial overgrowth, pancreatic insufficiency
• Chronic users of metformin or PPIs/H2 blockers: Impaired absorption
• Infants of B12-deficient mothers: Especially if exclusively breastfed

Toxicity/Excess

No Tolerable Upper Intake Level (UL) has been established for vitamin B12 due to its low potential for toxicity.

Safety profile:

• Absorption decreases dramatically with increasing doses
• Excess B12 is excreted in urine
• No adverse effects have been established from food or supplements at any dose level
• High-dose injections (1000+ mcg) used therapeutically without toxicity

Rare reported concerns (causality not established):

• Some observational studies suggest possible association between very high serum B12 levels and certain cancers, though this may reflect disease state rather than supplementation
• Acne-like eruptions reported rarely with high-dose supplementation

Food Sources

High B12 foods (mcg per serving):

• Clams (3 oz cooked: ~84 mcg)
• Beef liver (3 oz: ~70 mcg)
• Nutritional yeast, fortified (1 tbsp: ~2-4 mcg)
• Trout (3 oz: ~3.5 mcg)
• Salmon (3 oz: ~2.4 mcg)
• Tuna (3 oz: ~2.5 mcg)
• Beef (3 oz: ~1.5-2 mcg)
• Milk (1 cup: ~1.2 mcg)

Other sources:

• Eggs (~0.6 mcg per large egg, mostly in yolk)
• Cheese (varies by type: ~0.5-1.5 mcg/oz)
• Chicken (modest amounts: ~0.3 mcg/3 oz)
• Fortified cereals (varies widely: ~0.6-6 mcg per serving)
• Fortified plant milks (~0.5-2.5 mcg per cup)

Important notes:

• No naturally occurring B12 in plant foods (algae/spirulina contain inactive analogues)
• Fortified foods and supplements contain crystalline B12 with superior bioavailability
• Food-bound B12 requires gastric acid and pepsin for release

Special Populations

Vegans and vegetarians: MUST supplement or consume adequate fortified foods. Recommended: 250-500 mcg/day oral supplement or 2500 mcg/week. Sublingual and standard oral forms are equally effective for most people.

Pregnancy and lactation: Requirements increase modestly (2.6-2.8 mcg/day). B12 deficiency during pregnancy/lactation can cause developmental delays and neurological damage in infants. All pregnant vegans should supplement.

Elderly (>50 years): Institute of Medicine recommends meeting the RDA primarily through fortified foods or supplements due to high prevalence of food-bound B12 malabsorption.

Post-bariatric surgery: Require lifelong supplementation, often via sublingual or parenteral routes due to impaired absorption.

Patients with pernicious anemia: Require high-dose oral (1000-2000 mcg/day) or intramuscular B12; dietary intake alone is insufficient.

Infants: Exclusively breastfed infants of B12-deficient mothers are at high risk. Deficiency causes developmental regression and failure to thrive. Immediate treatment with B12 is critical.

Drug Interactions

Drugs that decrease B12 absorption:

• Metformin: Long-term use associated with B12 deficiency in 10-30% of users; mechanism involves calcium-dependent ileal membrane effects. Annual monitoring and supplementation recommended.
• Proton pump inhibitors (PPIs): Reduce gastric acid, impairing release of food-bound B12. Risk increases with duration of use (>2 years).
• H2-receptor antagonists: Similar mechanism to PPIs but less pronounced effect
• Colchicine: Impairs ileal absorption
• Cholestyramine: May bind B12
• Neomycin: Reduces absorption

Drugs potentially affected by B12:

• Chloramphenicol: May reduce hematological response to B12 treatment

Important clinical note: For patients on metformin or long-term acid suppression, consider annual B12 monitoring and recommend crystalline B12 supplements or fortified foods (which don't require gastric acid for absorption).

Caveats & Limitations

• HealthKit data reflects user-reported intake, not serum B12 levels or functional status
• Intake does not equal absorption; many factors affect B12 bioavailability
• Food databases may not distinguish between active B12 and inactive analogues
• High serum folate can mask hematological signs of B12 deficiency while neurological damage progresses
• Individual absorption capacity varies dramatically (especially in elderly and those with GI conditions)
• Supplement logging may be inconsistent
• Hepatic stores mean current intake may not reflect long-term status